United States securities and exchange commission logo





                          April 11, 2024

       Maria Zannes
       Chief Executive Officer
       bioAffinity Technologies, Inc.
       22211 W Interstate 10 Suite 1206
       San Antonio, TX 78257

                                                        Re: bioAffinity
Technologies, Inc.
                                                            Registration
Statement on Form S-1
                                                            Filed April 4, 2024
                                                            File No. 333-278512

       Dear Maria Zannes:

              This is to advise you that we have not reviewed and will not
review your registration
       statement.

               Please refer to Rules 460 and 461 regarding requests for
acceleration. We remind you
       that the company and its management are responsible for the accuracy and
adequacy of their
       disclosures, notwithstanding any review, comments, action or absence of
action by the staff.

                                                        Please contact Benjamin
Richie at 202-551-7857 with any questions.




                          Sincerely,


                          Division of Corporation Finance

                          Office of Industrial Applications and

                          Services
       cc:                                              Leslie Marlow